Fairey William

Director at AMERICAN CLAIMS EVALUATION INC · on record since Nov 2, 2023
Director at Rein Therapeutics, Inc. · on record since Jul 23, 2025
Director at Ascendis Pharma A/S · on record since Mar 18, 2026
Director at KalVista Pharmaceuticals, Inc. · on record since Jun 11, 2026
Chief Operating Officer at ChemoCentryx, Inc. · on record since Jan 5, 2018
EVP, Chief Commercial Officer at MyoKardia Inc · on record since Jan 28, 2019
Director at Mirum Pharmaceuticals, Inc. · on record since Aug 20, 2021

Insider trading activity of Fairey William

Transactions on record: 33; since Jan 5, 2018

Open-market buys: 0

Open-market sells: 2; $352.3K

Companies traded: 6; last filing Jun 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Fairey William has traded

Mirum Pharmaceuticals, Inc.12 tx · $155.1K · Jun 17, 2026
KalVista Pharmaceuticals, Inc.6 tx · Jun 11, 2026
Rein Therapeutics, Inc.1 tx · Jul 23, 2025
AMERICAN CLAIMS EVALUATION INC3 tx · Dec 6, 2024
MyoKardia Inc10 tx · $197.2K · Nov 19, 2020
ChemoCentryx, Inc.1 tx · Jan 5, 2018

Track record of Fairey William

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Fairey William

Co-insiders of Fairey William

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Mirum Pharmaceuticals, Inc.	Jun 17, 2026	AwardD	3,772	0.00 USD	—	SEC
Mirum Pharmaceuticals, Inc.	Jun 17, 2026	AwardD	1,980	0.00 USD	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-10,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-30,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-17,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Oct 2, 2025	AwardD	30,000	0.00 USD	$0	SEC
Rein Therapeutics, Inc.	Jul 23, 2025	AwardD	17,500	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 13, 2025	Sell	-3,203	48.42 USD	$155.1K	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	AwardD	3,977	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	ExerciseD	-5,703	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	AwardD	6,268	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	Exercise	5,703	—	—	SEC
AMERICAN CLAIMS EVALUATION INC	Dec 6, 2024	AwardD	35,000	0.00 USD	$0	SEC
KalVista Pharmaceuticals, Inc.	Oct 4, 2024	AwardD	10,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Aug 22, 2024	AwardD	2,725	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 7, 2024	AwardD	5,703	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 7, 2024	AwardD	8,779	0.00 USD	$0	SEC
KalVista Pharmaceuticals, Inc.	Apr 22, 2024	AwardD	17,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Nov 2, 2023	AwardD	5,450	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 14, 2023	AwardD	17,000	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 6, 2022	AwardD	12,750	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Aug 20, 2021	AwardD	34,000	0.00 USD	$0	SEC
MyoKardia Inc	Nov 19, 2020	OtherD	-69,500	—	—	SEC
MyoKardia Inc	Nov 19, 2020	Other	-42,199	—	—	SEC
MyoKardia Inc	Nov 19, 2020	OtherD	-39,022	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Mirum Pharmaceuticals, Inc.	Jun 17, 2026	AwardD	3,772	0.00 USD	—	SEC
Mirum Pharmaceuticals, Inc.	Jun 17, 2026	AwardD	1,980	0.00 USD	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-10,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-30,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Jun 11, 2026	OtherD	-17,000	—	—	SEC
KalVista Pharmaceuticals, Inc.	Oct 2, 2025	AwardD	30,000	0.00 USD	$0	SEC
Rein Therapeutics, Inc.	Jul 23, 2025	AwardD	17,500	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 13, 2025	Sell	-3,203	48.42 USD	$155.1K	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	AwardD	3,977	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	ExerciseD	-5,703	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	AwardD	6,268	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 2, 2025	Exercise	5,703	—	—	SEC
AMERICAN CLAIMS EVALUATION INC	Dec 6, 2024	AwardD	35,000	0.00 USD	$0	SEC
KalVista Pharmaceuticals, Inc.	Oct 4, 2024	AwardD	10,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Aug 22, 2024	AwardD	2,725	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 7, 2024	AwardD	5,703	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 7, 2024	AwardD	8,779	0.00 USD	$0	SEC
KalVista Pharmaceuticals, Inc.	Apr 22, 2024	AwardD	17,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Nov 2, 2023	AwardD	5,450	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 14, 2023	AwardD	17,000	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Jun 6, 2022	AwardD	12,750	0.00 USD	$0	SEC
Mirum Pharmaceuticals, Inc.	Aug 20, 2021	AwardD	34,000	0.00 USD	$0	SEC
MyoKardia Inc	Nov 19, 2020	OtherD	-69,500	—	—	SEC
MyoKardia Inc	Nov 19, 2020	Other	-42,199	—	—	SEC
MyoKardia Inc	Nov 19, 2020	OtherD	-39,022	—	—	SEC